GlobalData on MSN4mon
IDEAYA’s rare cancer drug shows promise as company lays out Phase III plansThe trial will enrol both patients eligible for enucleation and patients eligible for plaque brachytherapy. IDEAYA said that ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback